Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Founder BRCA1 and BRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history.

International journal of cancer - 20 May 2001

Tonin P N, Perret C, Lambert J A, Paradis A J, Kantemiroff T, Benoît M H, Martin G, Foulkes W D, Ghadirian P

Abstract excerpt

Recently, founder BRCA1 and BRCA2 mutations were identified in Canadian breast cancer and breast-ovarian cancer families of French ancestry. The presence of a breast cancer case diagnosed at younger than 36 years of age was strongly predictive of the presence of any founder mutation screened. Her...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Canada

Share to DNA Mutational Analysis

Share to Founder Effect

Share to Neoplasm Proteins

Share to Transcription Factors

Source

Identifiers

PMID: 11307153
DOI: 10.1002/1097-0215(20010520)95:3<189::aid-ijc1032>3.0.co;2-n

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-11307153-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Founder BRCA1 and BRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history.PMID 11307153Read ↗

Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history.Semantic proximity Read ↗

[The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].Semantic proximity Read ↗

The contribution of founder mutations to early-onset breast cancer in French-Canadian women.Semantic proximity Read ↗

Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer.Semantic proximity Read ↗

Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls.Semantic proximity Read ↗

A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population.Semantic proximity Read ↗

Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal.Semantic proximity Read ↗

Family History of Breast and Ovarian Cancers and BRCA1 and BRCA2 Mutations in a Population-Based Series of Early-Onset Breast CancerSemantic proximity Read ↗

Early onset breast cancer in Ashkenazi women carriers of founder BRCA1/2 mutations: beyond 10 years of follow-up.Semantic proximity Read ↗

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.Semantic proximity Read ↗

Germline TP53 mutational spectrum in French Canadians with breast cancer.Semantic proximity Read ↗

Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.